Drug Type Monoclonal antibody |
Synonyms NBG 030, NBG030 |
Target |
Mechanism GPCR antagonists(G-protein coupled receptor antagonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Discovery | JP | 29 Mar 2024 | |
Neoplasms | Discovery | JP | 29 Mar 2024 |